CD274 and cancer: There is a hypothesis that elevated LDH levels in cancer patients could counteract the efficacy of anti-PD-1/PD-L1 antibodies, which serve to prevent T cell exhaustion by blocking the expression of PD-1/PD-L1, potentially leading to an unfavorable prognosis [65].